SAN JOSE, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Silicon Valley TMS, an integrated, multidisciplinary private practice group providing a full range of outpatient mental health and chemical dependency services, today announced that it will be one of the first practices in Northern California to offer its patients access to BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for Obsessive-Compulsive Disorder (OCD). Silicon Valley TMS currently utilizes Deep TMS for patients living with depression in its San Jose, Pleasanton, Santa Cruz, San Francisco and Mountain View practices.
“Treating patients in one of the most populated states in the country, California physicians are grappling with meeting the needs of many individuals with mental illness in the state who do not receive necessary treatment,” said Saad A. Shakir, M.D., chief medical officer at Silicon Valley TMS. “At Silicon Valley TMS, we are committed to helping those in our local and surrounding communities living with mental illness by offering the most cutting-edge and effective treatments. We have applied therapeutic use of Deep TMS for our patients living with depression, seeing success rates as high as 86 percent among our patient population and are thrilled to add the latest Deep TMS device to our arsenal for our patients living with OCD, with the hope of seeing similar results.”
Deep TMS is a non-invasive treatment that has no systemic side effects and requires no hospitalization or anesthesia. As a treatment that does not require drugs, patients are awake during Deep TMS treatment and can return to daily activities, including driving, immediately following the session. Deep TMS works by stimulating the region of the brain responsible for OCD. The treatment was cleared by the FDA on August 20, 2018.
Silicon Valley TMS of Monterey Bay specializes in chronic pain management, Deep TMS therapy for depression and OCD, neuropsychiatry and ketamine treatments for depression. It has an armamentarium of treatment tools that include psychiatric consultation and psychotherapy, pharmacogenomics and Deep TMS services. Patients undergo an integrated collaborative approach to treatment including an in-depth initial evaluation by multiple members of the Silicon Valley TMS team. This unique, multi-pronged evaluation and treatment approach improves the wellness of the individual and yields improved physical, mental and optimal wellness and nutritional health.
About BrainsWay
BrainsWay Ltd./ BrainsWay USA (TASE: BRIN), is engaged in the research, development and sales and marketing of a medical system for non-invasive treatment of common brain disorders. The medical system developed and manufactured by the company is based on a unique breakthrough technology called Deep TMS, which can reach significant depth and breadth of the brain and produce broad stimulation and functional modulation of targeted brain areas. In the U.S., the Company’s device has been FDA cleared for the treatment of major depressive disorder (MDD) since 2013 and is now FDA cleared (De-Novo) for the treatment of Obsessive-Compulsive Disorder (OCD). The Company's systems have also received CE clearance and are sold worldwide for the treatment of various brain disorders.
About Silicon Valley TMS
Silicon Valley TMS is an integrated, multidisciplinary private practice group that includes physicians, mid-level providers, psychologists, mental health counselors, nursing and ancillary personnel including technicians. It provides the full range of outpatient mental health and chemical dependency services based on an individualized and tailored personal approach utilizing medical, psychological, behavioral and interpersonal interventions. Its professional staff uses the latest advances for effective evidence-based treatments. In addition to general psychiatric and psychological services it also provides innovative treatments that include noninvasive, neuromodulation including TMS. Silicon Valley TMS is proud to provide personalized medicine based on pharmacogenomics or individualized prescription sciences, and the full range of psychological and behavioral services based on evidence-based treatments.
BrainsWay Media Contact:
Sharon Golubchik
BrainsWay@antennagroup.com
201-465-8008